DAINIPPON SUMITOMO PHARMA
"Green Prism", the symbol of Dainippon Sumitomo Pharma Co., Ltd. is a motif in the design of the "Sun"-expressing a lively sense of energy, moving on toward tomorrow; "Light"-to convey the potential and hope of the future; and "Flower"-engendering the joyous and liberated sensation of basking in good health. A design crafted to embody preeminent research and development powers, a thorough support system, the spirit of challenge, and the other stances of Dainippon Sumitomo Pharma-a company bent on supplying all people with the strength to push on toward an even brighter tomorrow. Emanating from the symbol, furthermore, is the image of a network, steadily spreading out into the world.
DAINIPPON SUMITOMO PHARMA
Industry:
Biotechnology Health Care Health Diagnostics Pharmaceutical
Founded:
1984-01-01
Address:
Osaka, Osaka, Japan
Country:
Japan
Website Url:
http://www.ds-pharma.com
Total Employee:
5001+
Status:
Active
Contact:
81 6 6203 5321
Email Addresses:
[email protected]
Technology used in webpage:
SSL By Default Domain Not Resolving Amazon DigiCert SSL Amazon CloudFront Amazon Elastic Load Balancing Amazon Tokyo Region My Salesforce Adobe Analytics Amazon Paris Region
Similar Organizations
Dong-A Pharmaceutical
Dong-A Pharm is a leading pharmaceutical company in South Korea.
Dong-A Socio Holdings
Dong-A Socio Holdings has been the leading pharmaceutical company in South Korea.
Farmaku.com
Farmaku.com is a pharmaceutical health care company located in West Jakarta.
Panion & BF Biotech Inc.
Panion & BF Biotech Inc. is a biotech pharmaceutical company with diversified operations
Trans-hit Biomarkers
Trans-hit Biomarkers is a pharmaceutical company located in Laval.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Company's stock symbol is TYO:4506
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2016-12-21 | Tolero Pharmaceuticals | Tolero Pharmaceuticals acquired by Dainippon Sumitomo Pharma | 780 M USD |
| 2012-02-29 | Boston Biomedical | Boston Biomedical acquired by Dainippon Sumitomo Pharma | 2.63 B USD |
| 2009-09-03 | Sunovion Pharmaceuticals | Sunovion Pharmaceuticals acquired by Dainippon Sumitomo Pharma | 2.6 B USD |
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2021-10-01 | Roivant Sciences | Dainippon Sumitomo Pharma investment in Post-IPO Equity - Roivant Sciences | 200 M USD |
| 2020-08-05 | Myovant Sciences | Dainippon Sumitomo Pharma investment in Post-IPO Debt - Myovant Sciences | 200 M USD |
| 2019-07-24 | Drawbridge Health | Dainippon Sumitomo Pharma investment in Debt Financing - Drawbridge Health | N/A |
| 2019-04-05 | AlphaNavi Pharma | Dainippon Sumitomo Pharma investment in Series A - AlphaNavi Pharma | 900 M JPY |
| 2018-10-17 | Meltin MMI | Dainippon Sumitomo Pharma investment in Series B - Meltin MMI | 2.02 B JPY |
| 2018-10-05 | FunPep | Dainippon Sumitomo Pharma investment in Venture Round - FunPep | 460 M JPY |
| 2014-05-22 | Create Vaccine | Dainippon Sumitomo Pharma investment in Venture Round - Create Vaccine | 8.3 M USD |
| 2014-03-27 | Edison Pharmaceuticals | Dainippon Sumitomo Pharma investment in Venture Round - Edison Pharmaceuticals | 50 M USD |
| 2013-10-08 | Healios | Dainippon Sumitomo Pharma investment in Venture Round - Healios | 3 B JPY |
